reason report weekli
 equal-weight medic devic under-perform
broad market index increas
week versu gain result
medic devic hospit suppli index continu lag broad
market under-perform realiz
gain versu year-to-d gain
look ahead septemb confer attend
get full-sw european societi cataract refract
septemb transcathet cardiovascular therapeut
tct septemb addit also travel meet
surgeon account month
sector demand remain strong figur report
summar perform medic technolog hospit suppli
ipo past year note total compani
gone public sector sinc august mean gross
proce million per transact current
newli mint public compani black versu
gener neg return specif group mean
return trade mean multipl
revenu addit note current pipelin remain strong
smiledirectclub privat announc today compani plan
issu million share rang per share impli
rais billion
announc fda letter date august determin
compani provid suffici data initi human
clinic studi evo/evo visian implant
collam len myopia evo/evo visian toric implant
collam len myopia astigmat furthermor fda
recommend studi design modif plan
includ compani revis submiss come month
specif subject enrol trial undergo plan
peripher iridotomi importantli evo famili lens
commerci look captur minimum
refract marketplac base limit data
avail estim evo could potenti obtain approv
import disclosur analyst certif page report report constitut compendium report cover six
subject compani stephen inc choos provid specif disclosur compani mention refer
access current disclosur compani report client refer
contact stephen inc repres addit inform
wednesday august publish note e/v rate follow recent channel check tour
compani new world class acton massachusett manufactur facil channel check support growth
consensu rel premium valuat rel peer impli lofti street growth
expect simpli put possess distinct advantag strateg posit within rapidli grow
insulin-depend diabet marketplac pois realiz posit inflect growth profit
overcom revenu multipl recommend new invest cite likelihood
continu momentum passiv fund concentr within select med tech concern
thursday august rate report fiscal result default guidanc mix
versu consensu due tempor issu howev underli tenant stori remain much on-
track addit potenti addit misight regulatori pathway accordingli remain
confid abil conserv deliv organ revenu growth coupl oper margin
expans excess double-digit non-gaap earn growth next year period moreov
see potenti upsid renew advertis paragard fda approv misight
also thursday feder trade commiss grant clearanc o/v rate gkoss acquisit avedro inc
rate avdr recal view propos acquisit favor avdr possess highli defens disrupt
busi model scalabl keratoconu today larger comprehens ophthalmolog marketplac
furthermor o/v rate announc compani board director declar cash dividend per
common share payabl octob sharehold record octob
initi launch compani acrysof iq panoptix trifoc intraocular len patient undergo
cataract surgeri importantli len alreadi avail countri design optim intermedi vision
without compris near distanc vision aforement approv occur approxim quarter earlier
street expect
also tuesday august senseon hold inc rate announc public two-year
market clinic follow registri data europ compani eversens cgm sensor insert
total patient-year follow relat seriou advers event associ insert
remov found specif event per patient-year subject experienc infect
sensor side event per patient-year experienc irrit
wednesday august plc rate chairman chief execut offic omar ishrak
announc retir current role april follow end compani fiscal year mr ishrak
assum role execut chairman follow retir ceo addit board director
announc appoint geoff martha mr ishrak successor effect april mr martha current
serv mdt execut vice presid compani restor therapi group rtg also assum
compani newli creat role presid effect novemb lastli brett wall presid
mdt brain therapi divis succeed mr martha evp group presid rtf effect novemb
also wednesday inc rate announc compani complet enrol
transcend pivot clinic trial compani surveil drug-coat balloon dcb transcend trial enrol
patient global site evalu safeti efficaci surveil dcb compar commerci
avail dcb treatment peripher arteri diseas pad upper leg result complet
enrol increas revenu guidanc former rang million revis rang
million addit compani rais ep guidanc former rang
per share revis rang per share
inc announc compani open new clinic georgia call health new clinic
trial run compani success may lead wal-mart health clinic around countri clinic
provid patient access low-cost primari care includ treatment mental health issu furthermor
clinic offer dental counsel lab x-ray audiolog patient build next door store
thursday august food drug administr issu formal releas recommend
duodenoscop manufactur health care facil provid alik transit differ type duodenoscop
 use dispos endcap fulli dispos scope may repres less risk patient safeti view
statement potenti long-term posit rate compani dispos spyglass offer well
rate compani stand benefit increas devic volum highest margin
steril busi ast divis
note dollar million except per share data ep elgx nxtm
fulli tax pro forma
rate stephen inc overweight equal-weight underweight volatil susp suspend
percentag chang price
compani document stephen inc estim rate
stephen inc otherwis estim base upon consensu
file ipo
note million except per share data
non-cov compani mention list figur page figur
page
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
